The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20200385: Baxter International Inc.; Sanofi
20200530: Leidos Holdings, Inc.; Dynetics, Inc. Employee Stock Ownership Trust
20200598: Al Aqua (Cayman) Holdings Limited; AquaVenture Holdings Ltd.
20200618: Insight Partners XI, L.P.; Armis Security Ltd.
Urquid, Inc.
Revised Jurisdictional Thresholds for Section 7A of the Clayton Act
Illumina Inc./Pacific Biosciences of California, Inc., In the Matter of
The Federal Trade Commission authorized an action to block Illumina Inc.’s proposed $1.2 billion acquisition of Pacific Biosciences of California, alleging in an administrative complaint that Illumina is seeking to unlawfully maintain its monopoly in the U.S. market for next-generation DNA sequencing systems by extinguishing PacBio as a nascent competitive threat. The Commission vote to issue the administrative complaint and to authorize staff to seek a temporary restraining order and preliminary injunction was 5-0. On Jan. 2, 2020, the parties abandoned the transaction.